A Markov Model Assessing the Effectiveness and Cost-Effectiveness of FOLFOX Compared With FOLFIRI for the Initial Treatment of Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

A Markov Model Assessing the Effectiveness and Cost-Effectiveness of FOLFOX Compared With FOLFIRI for the Initial Treatment of Metastatic Colorectal Cancer

Published:2009-02 Issue:1 Volume:32 Page:49-55
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Tumeh John W.,Shenoy Pareen J.,Moore Susan G.,Kauh John,Flowers Christopher

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference44 articles.

1. Cancer Statistics, 2008.;Jemal;CA Cancer J Clin,2008

2. Combining chemotherapy and targeted therapies in metastatic colorectal cancer.;Rodriguez;World J Gastroenterol,2007

3. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.;Tournigand;J Clin Oncol,2004

4. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.;Colucci;J Clin Oncol,2005

5. Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients.;Rouits;Clin Cancer Res,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data;Cancer;2022-10-17

2. Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China;Journal of Medical Economics;2021-01-01

3. Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review;PharmacoEconomics;2020-04-22

4. Patient‐based cost‐effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4‐year prospective randomised phase II study;European Journal of Cancer Care;2019-12-11

5. Patient-Centered Outcomes in Radiation Oncology;Hematology/Oncology Clinics of North America;2019-12